EVAX Evaxion A/S - American Depositary Share

NASDAQ · Biotechnology
$3.04
Price · Aug 19, 2026
52W Range
$3–$12
5% of range
Analyst Rating
BUY
10 analysts
Price Target
$11
+270% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

EVAX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$3.04
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$3 – $12

EVAX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
EVAX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
EVAX
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
EVAX
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
EVAX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
EVAX
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
EVAX
Peer Median

EVAX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-08-13
Median target $10.00 +228.9%
Mean target $11.25 +270.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.19%
Next Report
Aug 20, 2026
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.50 $-0.31 -0.19%
Dec. 31, 2025 $-1.00 $-0.30 -0.70%
Sept. 30, 2025 $0.50 $0.41 0.09%
June 30, 2025 $-1.00 $-0.67 -0.33%
March 31, 2025 $-0.50 $-0.66 0.16%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 20 filers · $4.9M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (0 vs prior Q) 1 (-2 vs prior Q) 2 (0 vs prior Q) 5 (+2 vs prior Q) +50K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Merck & Co., Inc. $3,763,791 1,214,126 76.31% Shares
Ikarian Capital, LLC $231,564 74,698 4.69% Shares
Rathbones Group PLC $141,741 45,723 2.87% Shares
CITADEL ADVISORS LLC $113,410 36,584 2.30% Shares
RENAISSANCE TECHNOLOGIES LLC $104,780 33,800 2.12% Shares
Annis Gardner Whiting Capital Advisors, LLC $93,000 30,000 1.89% Shares
J. Safra Sarasin Holding AG $70,999 22,896 1.44% Shares
RHUMBLINE ADVISERS $67,723 21,849 1.37% Shares
JANE STREET GROUP, LLC $60,224 19,427 1.22% Shares
BOOTHBAY FUND MANAGEMENT, LLC $57,121 18,426 1.16% Shares
Stonepine Capital Management, LLC $54,442 17,562 1.10% Shares
SmartHarvest Portfolios, LLC $41,726 13,460 0.85% Shares
XTX Topco Ltd $39,987 12,899 0.81% Shares
WESBANCO BANK INC $31,000 10,000 0.63% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $24,800 8,000 0.50% Shares
UBS Group AG $19,453 6,275 0.39% Shares
GAMMA Investing LLC $14,297 4,612 0.29% Shares
Integrated Wealth Concepts LLC $1,990 642 0.04% Shares
SBI Securities Co., Ltd. $192 62 0.00% Shares
BESSEMER GROUP INC $0 18 0.00% Shares